Milnacipran Hydrochloride Tablet
Product Images NDC 51991-036

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Milnacipran Hydrochloride (NDC 51991-036). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Breckenridge Pharmaceutical, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Milnacipran 01)

Chemical structure of Milnacipran Hydrochloride showing a bicyclic ring with attached amino and ethyl groups and the hydrochloride component indicated.*

FDA Label Image

Principal Display Panel (Milnacipran 02)

A line chart depicting the percent of patients improved versus percent improvement in pain from baseline. The chart compares three groups: placebo, Milnacipran 100 mg, and Milnacipran 200 mg, showing trends of patient improvement across varying pain reduction percentages.*

FDA Label Image

Principal Display Panel (Milnacipran 03)

A line graph depicting the percent improvement in pain from baseline versus the percent of patients improved. The graph compares three groups: placebo, Milnacipran Hydrochloride 100 mg, and Milnacipran Hydrochloride 200 mg, illustrating differences in patient pain improvement over the percent improvement scale.*

FDA Label Image

Principal Display Panel (12.5 mg Tablet Bottle Label)

Milnacipran HCl Tablets packaging label showing 12.5 mg strength, oral tablet dosage form. The label includes manufacturer Centaur Pharmaceuticals Pvt. Ltd., distributor Breckenridge Pharmaceutical, Inc., and a quantity of 60 tablets. It features storage instructions, a barcode, and a notice to dispense the medication guide for patients.*

FDA Label Image

Principal Display Panel (25 mg Tablet Bottle Label)

Milnacipran HCl Tablets 25 mg film-coated tablets label showing the drug name, strength, and instructions. The label includes manufacturer Centaur Pharmaceuticals Pvt. Ltd. in India, distributor Breckenridge Pharmaceutical, Inc. in New Jersey, and packaging details including a quantity of 60 tablets. Storage and dispensing instructions are also visible.*

FDA Label Image

Principal Display Panel (50 mg Tablet Bottle Label)

Milnacipran HCl Tablets 50 mg label. The label shows Milnacipran hydrochloride tablets with a strength of 50 mg, available in a bottle of 60 tablets. It is an oral prescription drug manufactured by Centaur Pharmaceuticals Pvt. Ltd., India, and distributed by Breckenridge Pharmaceutical, Inc. Storage instructions and barcode are also included.*

FDA Label Image

Principal Display Panel (100 mg Tablet Bottle Label)

Milnacipran Hydrochloride 100 mg tablets packaging label. This oral tablet label shows the dosage strength of 100 mg, distributed by Breckenridge Pharmaceutical, Inc. It includes storage instructions, manufacturer information (Centaur Pharmaceuticals Pvt. Ltd., India), prescription-only status, package count of 60 tablets, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.